Cellectis (CLLS) Share-based Compensation (2015 - 2026)

Cellectis (CLLS) has 12 years of Share-based Compensation data on file, last reported at $1.7 million in Q1 2026.

• In Q1 2026, Share-based Compensation rose 70.39% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at -$1.6 billion (down 14.54% YoY), while the FY2025 annual figure was $6.1 million, up 92.93% from the prior year.
• Share-based Compensation declined to $1.7 million in Q1 2026, from $2.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $2.7 billion in Q3 2023 and bottomed at -$1.6 billion in Q2 2023.
• A 5-year average of -$115.9 million and a median of $1.3 million in 2025 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 199523.78% in 2023, down 81949.83% in 2023.
• Year by year, Share-based Compensation stood at $387000.0 in 2022, then jumped by 1094.06% to $4.6 million in 2023, then slumped by 80.87% to $884000.0 in 2024, then surged by 154.52% to $2.2 million in 2025, then retreated by 26.09% to $1.7 million in 2026.
• The last three Share-based Compensation figures came in at $1.7 million (Q1 2026), $2.2 million (Q4 2025), and -$1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison